Biogen Idec has announced plans to restructure, and will consolidate facilities and cease development of certain research projects in an effort to cut costs and focus on its most promising programs. George Scangos, the company’s recently appointed chief executive officer, commented at his appointment that he “planned to instill a sense of urgency in every aspect of the business to ensure that we execute at the highest levels and capitalize on our growth opportunities.” Biogen’s...